The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism
NCT02111473
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
49
Enrollment
OTHER
Sponsor class
Conditions
Hypogonadism
Interventions
DRUG:
Testosterone
Sponsor
Gulhane School of Medicine